atc code j06 atc code j06 atc code j06 immune sera and immunoglobulins is a therapeutic subgroup of the anatomical therapeutic chemical classification system, a system of alphanumeric codes developed by the world health organization (who) for the classification of drugs and other medical products. subgroup j06 is part of the anatomical group j antiinfectives for systemic use. atc codes j antiinfectives for systemic use j01 antibacterials for systemic use j02 antimycotics for systemic use j04 antimycobacterials j05 antivirals for systemic use human only j06 immune sera and immunoglobulins j07 vaccines atcvet only qj51 antibacterials for intramammary use qj54 antimycobacterials for intramammary use a b c d g h qi j l m n p r s v national issues of the atc classification may include additional codes not present in this list, which follows the who version. j06a immune sera j06aa immune sera j06aa01 diphtheria antitoxin j06aa02 tetanus antitoxin j06aa03 snake venom antiserum j06aa04 botulinum antitoxin j06aa05 gas-gangrene sera j06aa06 rabies serum j06b immunoglobulins j06ba immunoglobulins, normal human j06ba01 immunoglobulins, normal human, for extravascular administration j06ba02 immunoglobulins, normal human, for intravascular administration j06bb specific immunoglobulins j06bb01 anti-d (rh) immunoglobulin j06bb02 tetanus immunoglobulin j06bb03 varicella/zoster immunoglobulin j06bb04 hepatitis b immunoglobulin j06bb05 rabies immunoglobulin j06bb06 rubella immunoglobulin j06bb07 vaccinia immunoglobulin j06bb08 staphylococcus immunoglobulin j06bb09 cytomegalovirus immunoglobulin j06bb10 diphtheria immunoglobulin j06bb11 hepatitis a immunoglobulin j06bb12 encephalitis, tick-borne immunoglobulin j06bb13 pertussis immunoglobulin j06bb14 morbilli immunoglobulin j06bb15 parotitis immunoglobulin j06bb19 anthrax immunoglobulin j06bb30 combinations j06bc antibacterial monoclonal antibodies j06bc01 nebacumab j06bc02 raxibacumab j06bc03 bezlotoxumab j06bc04 obiltoxaximab j06bd antiviral monoclonal antibodies j06bd01 palivizumab j06bd02 motavizumab j06bd03 tixagevimab and cilgavimab j06bd04 ansuvimab j06bd05 sotrovimab j06bd06 regdanvimab j06bd07 casirivimab and imdevimab j06bd08 nirsevimab